38
Bioinformatics of the Brain
[148] M. R. Wrensch, Y. A. Minn, T. Chew, et al., “Epidemiology of primary
brain tumors: current concepts and review of the literature.,” Neuro-
oncology, vol. 4 4, pp. 278–99, 2002.
[149] J. Li, Y. Zhong, Z. Ma, et al., “Emotion reactivity-related brain net-
work analysis in generalized anxiety disorder: a task fmri study,” BMC
Psychiatry, vol. 20, 2020.
[150] S. A. Langenecker, H. J. Lee, and L. A. Bieliauskas, “Neuropsychol-
ogy of depression and related mood disorders,” In I. Grant & K. M.
Adams (Eds.), Neuropsychological assessment of neuropsychiatric and
neuromedical disorders, Oxford University Press, 3rd ed., pp. 523–559,
2009.
[151] J. L. Levenson, “The american psychiatric publishing textbook of psy-
chosomatic medicine: psychiatric care of the medically ill,” American
Psychiatric Publishing, 2005.
[152] D. Badre and D. E. Nee, “Frontal cortex and the hierarchical control of
behavior,” Trends in Cognitive Sciences, vol. 22, pp. 170–188, 2018.
[153] E. Lugaresi and P. L. Parmeggiani, “Somatic and autonomic regulation
in sleep : physiological and clinical aspects,” Springer, 1997.
[154] J. P. Pandarakalam, “Where scizophrenia and consciousness intersect:
Disorders of consciousness in schizophrenia,” Neuroquantology, vol. 17,
pp. 121–139, 2019.
[155] J. Tomasik, E. Schwarz, P. C. Guest, et al., “Blood test for schizophre-
nia,” European Archives of Psychiatry and Clinical Neuroscience,
vol. 262, pp. 79–83, 2012.
[156] W. T. Carpenter and R. Tandon, “Psychotic disorders in dsm-5: sum-
mary of changes,” Asian journal of psychiatry, vol. 6 3, pp. 266–8, 2013.
[157] K. H. Karlsgodt, D. Sun, and T. D. Cannon, “Structural and functional
brain abnormalities in schizophrenia,” Current Directions in Psycholog-
ical Science, vol. 19, pp. 226–231, 2010.
[158] P. V. Gejman, A. R. Sanders, and J. Duan, “The role of genetics in the
etiology of schizophrenia,” The Psychiatric clinics of North America,
vol. 33 1, pp. 35–66, 2010.
[159] M. I. Herz, J. S. Lamberti, J. Mintz, et al., “A program for relapse
prevention in schizophrenia: a controlled study,” Archives of general
psychiatry, vol. 57 3, pp. 277–283, 2000.
[160] K. R. Patel, J. Cherian, K. Gohil, et al., “Schizophrenia: overview and
treatment options,” P & T: a peer-reviewed journal for formulary man-
agement, vol. 39 9, pp. 638–645, 2014.